Your Mounjaro price guide · October 2026
List of GLP-1 Receptor Agonists in the UK (October 2026)
The main GLP-1 receptor agonists in UK use as of October 2026 are tirzepatide (Mounjaro), semaglutide (Wegovy, Ozempic and Wegovy tablets), liraglutide (Saxenda and Erly) and orforglipron (Foundayo). Tirzepatide also activates the GIP receptor, so it is a dual agonist.1 All are prescription-only.
One pen. Four weekly doses.
New customers£40 off your first order with code FIRST40. Standard price £169.99.

From your first consultation to ongoing care.
- GPhC-registered UK pharmacy
- Prescriber assessment
- Temperature-controlled delivery
- Advice from our pharmacy team
Compare UK Mounjaro Prices
Prices checked 10 October 2026
| Provider | 2.5mg | 5mg | 7.5mg | 10mg | 12.5mg | 15mg | Notes |
|---|---|---|---|---|---|---|---|
| £129.99First orderReorders £144.99 | £178.99First orderReorders £193.99 | £239.99First orderReorders £254.99 | £250.99First orderReorders £265.99 | £279.99First orderReorders £294.99 | £289.99First orderReorders £304.99 | Consultation and next-day tracked delivery included | |
| Boots Online Doctor | £179.00 | £199.00 | £259.00 | £299.00 | £319.00 | £339.00 | Free click & collect; cold-chain home delivery chargeable |
| Asda Online Doctor | £148.97 | £188.97 | £248.97 | £278.97 | £287.47 | £298.97 | Refrigerated delivery from £4.50; free click & collect |
| MedExpress | £179.99 | £189.99 | £249.99 | £279.99 | £299.99 | £309.99 | Delivery £2.90 to £3.95; new-customer discount at checkout |
| Simple Online Pharmacy | £169.00 | £199.99 | £259.99 | £279.99 | £299.99 | £319.99 | Delivery £4.99 per order |
| Oxford Online Pharmacy | £143.96 | £188.96 | £248.96 | £278.96 | £288.96 | £309.95 | Free consultation; cold delivery £5.49 |
| Chemist4U | £148.00 | £188.00 | £248.00 | £278.00 | £288.00 | £298.00 | Consultation included; free temperature-controlled delivery |
| Chemist Click | £163.99 | £173.99 | £232.99 | £259.99 | £279.99 | £299.49 | Cold-chain delivery charged; £20 off with code |
| Click Pharmacy | £169.99 | £189.99 | £239.99 | £269.99 | £289.99 | £299.99 | Free assessment; delivery £3.50 to £7.95 |
| Medino | £147.99 | £169.99 | £249.99 | £269.99 | £299.99 | £319.99 | Consultation and delivery included |
Prices collected weekly from each provider's published price list.
A quick overview
What to know
before you start.
-
Tirzepatide (Mounjaro) is a GLP-1 medicine that also activates GIP, so it is a dual-action treatment.
-
Semaglutide is sold as Wegovy and Ozempic, and as Wegovy tablets, a once-daily oral form.
-
Liraglutide is a daily injection, unlike once-weekly Mounjaro and Wegovy.
-
Orforglipron (Foundayo) is an oral tablet described as a small-molecule GLP-1 receptor agonist.
-
Never combine GLP-1 medicines or use unlicensed 'research' peptides; a prescriber chooses the right option.
In this guide
01 · The list
GLP-1 receptor agonists list including tirzepatide
Four active ingredients make up the list most UK readers meet.
| Active ingredient | Brand names | Form and schedule | Receptors |
|---|---|---|---|
| Tirzepatide | Mounjaro | Once-weekly pen in six strengths, 2.5mg to 15mg1 | GIP and GLP-11 |
| Semaglutide | Wegovy, Ozempic, Wegovy tablets | Once-weekly pen on a ladder of 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg; also a tablet1820 | GLP-1 |
| Liraglutide | Saxenda, Erly | Daily injection, supplied at 6mg/ml | GLP-1 |
| Orforglipron | Foundayo | Film-coated tablet21 | GLP-1 (oral small molecule)23 |
02 · Mounjaro
Is Mounjaro a GLP-1 agonist?
Yes. Tirzepatide activates two natural gut-hormone receptors at once, GIP and GLP-1, which is what separates it from single-action medicines such as semaglutide.1 If weight management is your goal, see the weight loss clinic for the next step, or read how these medicines work in the body.
03 · How the medicines differ
How the medicines differ
The practical differences are the receptors targeted, the schedule and the form. Mounjaro and the Wegovy pen are once weekly, and liraglutide is a daily injection. Wegovy tablets and Foundayo are oral options.2021
Mounjaro starts at 2.5mg and moves through its strengths under prescriber review.1 For a general overview, see our guide to a GLP-1 receptor agonist.
04 · Not on the licensed list
Not on the licensed list
Retatrutide has no UK licence, and unlicensed 'research' peptides or compounded copies have no safety data and no regulated supply chain. Promises of faster results outside a licensed pathway are the warning sign. Supplements sold as natural alternatives are not GLP-1 medicines; see our page on natural GLP-1 receptor agonists.
05 · Safety and combinations
Safety and combinations
Mounjaro must not be combined with other GLP-1 medicines, so you take one at a time. Because it slows stomach emptying, it can affect how quickly some oral medicines are absorbed, particularly when you start or increase the dose. Tell your prescriber about everything you take, especially warfarin or other narrow-margin medicines, insulin, or sulfonylureas, where doses may need reducing to avoid low blood sugar.
Report any suspected side effect through the Yellow Card scheme.19 Our guide to the adverse effects of GLP-1 receptor agonists covers what to expect. Seek immediate medical help for severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin or eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing.
06 · Cost and access
Cost and access
Prices differ by medicine and dose. A new customer's first 2.5mg Mounjaro pen costs £129.99 with code FIRST40 (standard price £169.99), and the first Wegovy pen is £99.99 as a first-order price. For a side-by-side view, see the price per month by medicine and our GLP-1 cost guide. Tablet prices are on the product pages.
How ordering works
How ordering works at EverydayMeds
Three steps, with our pharmacy team alongside you.
Step 1: Online consultation — 5–10 minutes
Complete a confidential health questionnaire covering BMI, medical history and current medication. No payment is taken until you're approved.
Step 2: Prescriber review — usually same day
A UK registered prescriber checks your suitability against the licensed criteria (BMI ≥30, or ≥27 with a weight-related condition) and contraindications, and confirms your starting dose.
Step 3: Next-day tracked delivery
Dispensed by our GPhC-registered pharmacy in temperature-controlled packaging with needles and a sharps bin included. Orders approved by 3pm for next-day tracked delivery.
Prescription and dispatch follow clinical approval. Confirm current delivery options when ordering.
Afterwards you're not on your own: dose-change reviews are built in before each step up, our pharmacist team is available for side-effect questions, and repeat orders re-check suitability rather than auto-shipping.
Your questions, answered
Mounjaro price UK — frequently asked questions
Answers to common questions about Mounjaro prices, NHS access and ongoing treatment.
Ask our pharmacy teamIs Mounjaro a GLP-1 agonist?
Are GLP-1 receptor agonists peptides?
Who should avoid GLP-1 medicines?
What is known as the 'poor man's Ozempic'?
What is a cheaper alternative to Ozempic?
Is there a drug better than Ozempic?

Clinically reviewed by
Mahommed Zunaid Ayub Patel
Superintendent Pharmacist
Accountable for the safe running of our registered pharmacy — from dispensing checks to delivery.
GPhC registration no. 2217101 · check the GPhC register
- Reviewed
- Last updated
- Next review
How we source our information
How we source our information: every clinical statement on this page is drawn from the sources below. Our prices are shown live from our pharmacy's product listings, and competitor prices show the date they were collected.
Sources — 9 references
- Mounjaro KwikPen — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
- MHRA — guidance on contraception with GLP-1/GIP medicines; counterfeit medicine alerts and Yellow Card scheme
- Aronne LJ, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5). N Engl J Med 2025
- Wegovy — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC)
- MHRA Yellow Card scheme — report a side effect
- Wegovy tablets (oral semaglutide) — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
- Foundayo (orforglipron) film-coated tablets — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
- Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity (OASIS 4). N Engl J Med 2025
- Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, for Obesity Treatment (ATTAIN-1). N Engl J Med 2025
EverydayMeds is operated by OVIO Ltd · GPhC-registered pharmacy 9012878 · Registered premises, Leicester · Superintendent Pharmacist: Mahommed Zunaid Ayub Patel


